Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports the company's current EPS (TTM) is ₹232.64. In 2022 the company made an earnings per share (EPS) of ₹276.26 a decrease over its 2021 EPS that were of ₹298.50.